2021
DOI: 10.51668/bp.8321214s
|View full text |Cite
|
Sign up to set email alerts
|

Tratamiento multidisciplinar para la fibromialgia y el síndrome de fatiga crónica: una revisión sistemática

Abstract: Los objetivos de esta revisión sistemática fueron examinar la eficacia del tratamiento multidisciplinar (TM) aplicado a pacientes con fibromialgia y síndrome de fatiga crónica (SFC), junto con la exploración de predictores, mediadores y moderadores de resultados. Se realizó una búsqueda bibliográfica exhaustiva en las bases de datos Medline, PsycInfo, Scopus y Cochrane Library en el período 1990-2018. En total, 31 artículos de fibromialgia y seis de SFC fueron identificados. Los resultados reflejaron que en fi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
3
0
1

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 0 publications
0
3
0
1
Order By: Relevance
“…The main treatment chosen by patients continues to be pharmacological, such as amitriptyline, or other tricyclic antidepressants, even though they are not explicitly prescribed for people with fibromyalgia [ 10 ]. Although the recommended treatment includes the use of medication of various kinds, along with moderate physical exercise and psychological therapy [ 11 , 12 ], technological advances in neuroimaging since the 1970s have brought about the use of different neurofeedback techniques as symptomatic therapy in the treatment, amongst other symptoms, of pain, insomnia and depression [ 13 ]. However, even now, any kind of neurofeedback as treatment is still not used as a generalist therapy for fibromyalgia [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…The main treatment chosen by patients continues to be pharmacological, such as amitriptyline, or other tricyclic antidepressants, even though they are not explicitly prescribed for people with fibromyalgia [ 10 ]. Although the recommended treatment includes the use of medication of various kinds, along with moderate physical exercise and psychological therapy [ 11 , 12 ], technological advances in neuroimaging since the 1970s have brought about the use of different neurofeedback techniques as symptomatic therapy in the treatment, amongst other symptoms, of pain, insomnia and depression [ 13 ]. However, even now, any kind of neurofeedback as treatment is still not used as a generalist therapy for fibromyalgia [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…Fibromyalgia (FM) is characterized by chronic, widespread musculoskeletal pain with multiple tender points and generalized tenderness with muscle stiffness, joint stiffness, sleep disturbances, fatigue, mood, cognitive dysfunction, anxiety, depression, general tenderness, and inability to perform daily life activities. Regarding prevalence, it is estimated that 4% of the world’s population is affected by FM, mainly in women aged 20–55 years [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…In FM, there is increasing evidence of inflammatory mechanisms of neurogenic origin in peripheral tissues, the spinal cord, and the brain. Cytokines/chemokines, lipid mediators, oxidative stress and various plasma-derived factors underlie the inflammatory state in fibromyalgia [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…El tratamiento, de carácter multidisciplinar, está dirigido a la mejora de los síntomas y no a la cura de la enfermedad (González et al, 2015;Sánchez et al, 2021), con el fin de mejorar la calidad de vida de los pacientes de FM. Se diferencian dos tipos de tratamientos, los farmacológicos y los no farmacológicos (Davenport, 2012;Imamura et al, 2009).…”
Section: Introductionunclassified